Zhou, S., Deng, M., Bian, X., Shi, J., Liang, R., & Tao, M. (2024). Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma: Role of ADRB2 and mTOR/PI3K/AKT in LUAD. Cellular and Molecular Biology, 70(2), 120–127. https://doi.org/10.14715/cmb/2024.70.2.17